While more than 95% of CML patients carry the BCR-ABL1 fusion gene5, a minor proportion of acute lymphocytic leukemias (ALL) and acute myeloid leukemias (AML) may also harbor the BCR-ABL1 fusion6. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.